Successful treatment of fulminant neonatal enteroviral myocarditis in monochorionic diamniotic twins with cardiopulmonary support, intravenous immunoglobulin and pocapavir

BMJ Case Reports
Shahnawaz M AmdaniKathleen Simpson

Abstract

Neonatal cardiogenic shock most commonly occurs due to critical congenital heart disease, sepsis, metabolic disorder or arrhythmias. In particular, enterovirus infections are common in the neonatal period, and patients can present with fulminant myocarditis. Early recognition is imperative due to its high morbidity and mortality without prompt and aggressive treatment. We present the successful treatment of fulminant neonatal enteroviral myocarditis in a pair of monochorionic diamniotic twins with cardiopulmonary support, intravenous immunoglobulin and pocapavir, an enteroviral capsid inhibitor. The twins took an almost exact parallel hospital course, including day of extracorporeal membrane oxygenation (ECMO) cannulation, day of ECMO decannulation, improvement of cardiac function, discharge and status at follow-up. While it was difficult to assess the relative contribution of each intervention, our case shows promise in the use of pocapavir for treatment of severe enteroviral infections. Remarkably, both twins demonstrated remarkable recovery within 2 weeks, underscoring that early aggressive cardiopulmonary support, and potentially pocapavir, contributed to their recovery.

References

Feb 1, 1988·Pediatrics in Review·M H Lees, D H King
Dec 23, 1999·The Pediatric Infectious Disease Journal·M H Sawyer
Aug 24, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·D InwaldM Burch
Jun 4, 2005·BMC Cardiovascular Disorders·Joan L RobinsonTerry P Klassen
Feb 2, 2006·Heart·N AmabileC Ovaert
Mar 21, 2008·International Journal of Cardiology·Duck Won BangYoung Joo Kwon
Mar 24, 2009·Seminars in Fetal & Neonatal Medicine·Marc Tebruegge, Nigel Curtis
Jul 29, 2009·Antimicrobial Agents and Chemotherapy·M Steven ObersteMarc S Collett
Nov 7, 2009·Current Treatment Options in Neurology·Sumit ParikhThe Mitochondrial Medicine Society
Nov 17, 2009·The Journal of Perinatal & Neonatal Nursing·Jeannine G Jones, Sandra L Smith
Oct 1, 2001·Paediatrics & Child Health·A B Dancea
May 7, 2010·Archives of Disease in Childhood. Fetal and Neonatal Edition·Matthias W FreundMalgorzata A Verboon-Maciolek
Jul 14, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Kate MaddenSatish K Rajagopal
Jul 16, 2010·Journal of Paediatrics and Child Health·Geethanjali RamachandraPadmanabhan Ramnarayan
Jan 5, 2011·The Journal of Pediatrics·Sarah A TeeleRavi R Thiagarajan
Apr 8, 2014·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Stephanie J BisselClayton A Wiley
Sep 18, 2014·The Pediatric Infectious Disease Journal·Sanet Torres-TorresRussell J McCulloh
Sep 26, 2017·Journal of Investigative Medicine High Impact Case Reports·Samuel G WittekindRyan A Moore

❮ Previous
Next ❯

Citations

Dec 11, 2019·Antimicrobial Agents and Chemotherapy·Eric RhodenWilliam C Weldon
Oct 14, 2020·Nature Reviews. Cardiology·Carsten TschöpeSophie Van Linthout

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.